Step inside one of the nation's premier cancer centers for an exclusive laboratory tour and research insights, as well as a hosted lunch with senior executives at USC Norris Comprehensive Cancer Center, led by George Yaghmour, MD hematologist/oncologist, transplant physician, and clinical leader in cutting-edge cancer therapies at Keck Medicine of USC. Dr. Yaghmour specializes in hematologic malignancies, stem cell transplantation, and advanced cellular therapies, with a focus on early-phase clinical trials and translating innovative immunotherapy breakthroughs into real-world patient care.
Enjoy a guided insider tour of the Norris Cancer Hospitals Stem Cell Transplant and Cellular Therapy Program, where you'll explore advanced technologies and pioneering approaches shaping the future of blood cancer treatment and beyond, alongside insights from Preet Chaudhary, MD, whose laboratory is developing next-generation cellular therapies, including Synthetic Immune Receptor T-cell (SIR-T) therapy a promising USC-developed platform with the potential to transform cancer treatment, including for solid tumors such as prostate cancer (Dr. Chaudhary will participate when available).
As one of the original eight National Cancer Institute-designated comprehensive cancer centers, USC Norris is ranked among the top 25 hospitals for cancer nationally, and this experience offers a rare, firsthand look at how groundbreaking therapies move from laboratory discovery to clinical application under the leadership of physicians advancing innovation into patient care. Following the tour and discussion, enjoy a hosted lunch with executive leadership from Oncology Operations, including Marty Sargeant, CEO of Keck Medical Center of USC, Smitha Ravipudi, CEO of USC Care Medical Group, and Stephen Miller, Chief of Operations at Norris Cancer Hospital and Chief of Cancer Service Line, offering an intimate opportunity to engage with leaders at the forefront of cancer care innovation and the future of oncology.
This experience includes:
Notice of Updated Buyer Terms of Use
We have recently updated our Buyer Terms of Use. We encourage you to review the revised terms to ensure continued understanding and compliance. By continuing to use our platform, you acknowledge and agree to the updated terms. View the updated Terms of Use